ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

43,359Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 3593

$1.53M Total Retail Price of All Prescriptions

Rank: 44 out of 3593

4,400 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

0% of this provider’s 4,400 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 4,400 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 35,551 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

14% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$35 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

10 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 3,940 3,152 10 1 1
LISINOPRIL 2,328 1,978 10 2 2
METFORMIN HCL 1,853 1,568 10 3 6
OMEPRAZOLE 1,554 1,293 4 5
LEVOTHYROXINE SODIUM 1,501 1,316 5 4
FENOFIBRATE 1,261 954 10 6 39
LISINOPRIL-HYDROCHLOROTHIAZIDE 1,152 959 10 7 26
AMLODIPINE BESYLATE 1,152 1,006 7 3
ZOLPIDEM TARTRATE 1,072 825 9 12
TRAMADOL HCL 998 827 10 17
HYDROCODONE-ACETAMINOPHEN 714 497 S3 11 7
DOXAZOSIN MESYLATE 688 601 12 63
ATENOLOL 646 548 13 11
LIOTHYRONINE SODIUM 580 504 10 14 260
VYTORIN 580 469 10 14 216
LOSARTAN POTASSIUM 521 502 16 14
GABAPENTIN 520 374 17 16
FUROSEMIDE 518 430 18 9
DOXYCYCLINE HYCLATE 515 417 19 141
CRESTOR 467 411 20 21
DIGOXIN 460 421 21 58
METOPROLOL TARTRATE 455 412 22 8
GLYBURIDE-METFORMIN HCL 449 346 R 23 95
HYDROCHLOROTHIAZIDE 425 339 24 10
ALENDRONATE SODIUM 417 375 25 22
PRAVASTATIN SODIUM 405 342 26 13
SERTRALINE HCL 387 278 27 28
LOSARTAN-HYDROCHLOROTHIAZIDE 370 337 28 48
SULFAMETHOXAZOLE-TRIMETHOPRIM 369 301 29 102
MELOXICAM 368 290 30 29
FLUTICASONE PROPIONATE 348 267 31 32
METOPROLOL SUCCINATE 344 244 32 19
CIPROFLOXACIN HCL 343 290 33 52
METOCLOPRAMIDE HCL 343 282 33 145
TIZANIDINE HCL 341 237 35 120
CARVEDILOL 330 295 36 23
RANITIDINE HCL 310 240 37 27
LOVASTATIN 308 279 38 20
FINASTERIDE 302 284 39 79
CITALOPRAM HBR 287 218 40 25
ATORVASTATIN CALCIUM 267 228 41 15
LANTUS SOLOSTAR 264 212 42 122
WARFARIN SODIUM 249 201 43 18
LANTUS 242 205 44 57
GLIMEPIRIDE 241 207 45 44
TAMSULOSIN HCL 227 200 46 33
ALLOPURINOL 215 175 47 35
GLIPIZIDE 212 172 48 40
TRAZODONE HCL 211 168 49 53
VERAPAMIL ER 196 176 50 99
FLUOXETINE HCL 188 142 51 60
NAPROXEN 181 143 52 68
PANTOPRAZOLE SODIUM 177 153 53 45
POTASSIUM CHLORIDE 174 163 54 24
TRIAMTERENE-HCTZ 172 142 55 66
SPIRONOLACTONE 171 139 56 86
CLONIDINE HCL 171 146 56 41
THEOPHYLLINE ANHYDROUS 171 155 56 286
PREDNISONE 170 144 59 49
PEN NEEDLE 168 137 60 188
METHYLPREDNISOLONE 166 134 61 103
DONEPEZIL HCL 162 153 62 31
OXYBUTYNIN CHLORIDE 161 151 63 104
VENTOLIN HFA 157 101 64 80
PROAIR HFA 156 115 65 54
ISOSORBIDE MONONITRATE ER 150 130 66 61
AZITHROMYCIN 143 116 67 34
NIFEDIPINE ER 142 129 68 75
INSULIN SYRINGE 139 113 69 91
PAROXETINE HCL 138 98 70 62
DILTIAZEM ER 132 116 71 194
BENAZEPRIL HCL 124 99 72 69
DILTIAZEM 24HR ER 123 121 73 177
ADVAIR DISKUS 122 98 74 47
AMOX TR-POTASSIUM CLAVULANATE 119 97 75 138
DILTIAZEM 24HR CD 118 98 76 173
METFORMIN HCL ER 114 93 77 67
AMITRIPTYLINE HCL 111 78 R 78 90
ENALAPRIL MALEATE 109 79 79 38
KETOCONAZOLE 107 87 80 118
TRIAMCINOLONE ACETONIDE 105 90 81 119
HUMALOG 101 88 82 249
SYNTHROID 101 88 82 51
IBUPROFEN 97 68 84 43
ANASTROZOLE 96 83 85 458
ESTRADIOL 95 79 R 86 174
TESTOSTERONE CYPIONATE 94 61 S3 87 289
NAMENDA 92 92 88 50
MECLIZINE HCL 92 77 88 96
PROPRANOLOL HCL 91 64 90 181
NOVOLOG FLEXPEN 85 70 91 234
TERAZOSIN HCL 83 82 92 115
CHOLESTYRAMINE 80 70 93 386
GLIPIZIDE ER 79 70 94 101
CLOPIDOGREL 78 70 95 30
AMOXICILLIN 75 54 96 128
CLOTRIMAZOLE-BETAMETHASONE 75 66 96 94
FLUCONAZOLE 75 57 96 229
GLYBURIDE 75 72 R 96 55
BUPROPION HCL SR 74 51 100 207
ZETIA 74 65 100 110
SPIRIVA 71 68 102 87
BUSPIRONE HCL 70 54 103 156
BUMETANIDE 68 61 104 148
CARTIA XT 67 66 105 299
CYMBALTA 67 52 105 73
VENLAFAXINE HCL 65 57 107 267
NITROSTAT 64 56 108 224
VENLAFAXINE HCL ER 61 44 109 178
SINGULAIR 60 39 110 77
ROPINIROLE HCL 60 60 110 144
METRONIDAZOLE 58 47 112 268
SUCRALFATE 58 53 112 237
PLAVIX 57 51 114 42
HYDRALAZINE HCL 57 49 114 107
CEPHALEXIN 55 44 116 150
ACYCLOVIR 54 37 117 259
DICLOFENAC SODIUM 50 35 118 74
AGGRENOX 50 42 118 288
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 24, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.